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The molecular events of cardiac lineage speci®cation and differentiation are largely unknown. Here we describe the
involvement of a growth factor with an EGF-like domain, Cripto-1 (Cr-1), in cardiac differentiation. During embryonic
development, Cr-1 is expressed in the mouse blastocyst, primitive streak, and later is restricted to the developing heart.
To investigate the role of Cr-1, we have generated Cr-1-negative embryonic stem (ES) cell lines by homologous recombina-
tion. The resulting double ``knockout'' ES cells have selectively lost the ability to form beating cardiac myocytes, a process
that can be rescued by reintroducing Cr-1 gene back into the Cr(0/0) cells. Furthermore, the lack of functional Cr-1
is correlated with absence of expression of cardiac-speci®c myosin light and heavy chain genes during differentiation.
Differentiation into other cell types including skeletal muscle is not disrupted. These results suggest that Cr-1 is essential
for contractile cardiomyocyte formation in vitro. q 1998 Academic Press
Key Words: homologous recombination; gene targeting; markers for ectoderm, mesoderm and endoderm; teratocarcino-
mas; mutant phenotype; rescue.
INTRODUCTION tively little is known about the early stage of vertebrate
heart development. In this report, we describe the involve-
ment of Cripto-1 (see below) in the early stages of differenti-The development of the heart is a complex process com-
ation of cardiomyocytes.posed of two major stages: an early speci®cation and differ-
Cripto-1 (Cr-1), encoded by the teratocarcinoma-derivedentiation of cardiomyocytes and later morphogenesis
growth factor-1 (tdgf-1) gene (Liguori et al., 1996), is a(Olson and Srivastava, 1996). Murine cardiac progenitor
growth factor with an epidermal growth factor-like motifcells derive from the anterior lateral plate mesoderm that
(Ciccodicola et al., 1989). Although Cr-1 folds in the charac-arises from the primitive streak on the sixth day of gestation
teristic EGF-like manner using its six cysteine residues, the(E6.5) (Olson and Srivastava, 1996). These cells differentiate,
resulting polypeptide is unable to bind to members of theexpress cardiac muscle structural genes such as myosin
EGF receptor family due to truncation of some sequencesheavy chains and atrial and ventricular myosin light chains
(Brandt et al., 1994). Cr-1 is a growth factor for mammary(Kubalak et al., 1994; O'Brien et al., 1993), and form the
cells by interaction with an unidenti®ed receptor to activateprimitive cardiac tube at E7.5±8.0 (Lyons et al., 1990; Mor-
intracellular components through ras/raf/MAPK pathwaykin, 1993; Sassoon et al., 1988). The newly formed cardiac
(Kannan et al., 1997). Cr-1 and the related Cryptic gene havetube undergoes extensive morphological changes before
been assigned to a distinct family, with the proposed name,forming the mature heart. Through gene targeting tech-
CFC (Shen et al., 1997).niques, many genes have been identi®ed as being involved
Both human and mouse Cr-1 are encoded by 6 exons (exonin the later processes of heart development. However, rela-
4 contains the EGF-like domain) producing (in mouse) a
secreted protein of 171 amino acid residues (Liguori et al.,
1996). Cr-1 is expressed at three main stages in develop-1 The last two authors contributed equally.
ment. The earliest expression of Cr-1 occurs in 4-day mouse2 To whom correspondence and reprint requests should be ad-
blastocysts in both trophoblast and inner cell mass cellsdressed. Fax: (619) 646-3195. E-mail: eadamson@ljcrf.edu or eadam
son@burnham-inst.org. (Johnson et al., 1994). At day 6.5, Cr-1 is present in epiblast
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pCR-KO2 and selected in medium containing hygromycin B (400cells and is strongly expressed at the primitive streak stage
mg/ml) and gancyclovir (0.2 mM).in the forming mesoderm. Then, a pattern restricted to de-
Differentiation of ES cells. Embryoid bodies (EBs) were formedveloping heart structures occurs (Dono et al., 1993; Johnson
by ES cell aggregate culture in hanging drops (Wobus et al., 1991).et al., 1994) with Cr-1 speci®cally expressed in the myocar-
The differentiation medium was ES culture medium containingdium of the developing heart tubes in 8.5-day-old embryos
20% fetal calf serum but without LIF. Rhythmic beating of theand in the out¯ow region, conotruncus, of the heart at 9.5±
EBs, indicating cardiac muscle differentiation, was monitored by
10 days gestation, when the heart develops into a functional daily inspection of the cultures using phase microscopy. Induction
chambered organ. After 10.5 days of development, no in of differentiation into skeletal muscle was performed by the
situ hybridization signals have been detected in the embryo method similar to that described by Weitzer (Weitzer et al., 1995).
(Dono et al., 1993). This pattern of Cr-1 expression suggests Induction of differentiation of ES cells into neurons was performed
a role in the process of gastrulation, wherein the ectoderm by a method similar to that described by Bain (Bain et al., 1995).
Screening for recombinant clones. Genomic DNA samplesgerm layer gives rise to the mesoderm tissues including
were extracted from individual clones and examined for the pres-those producing the heart and somites. In addition, the
ence of a targeted allele by PCR analysis using Taq Extender PCRhighly restricted expression patterns of Cr-1 raise the possi-
additive system (Stratagene, San Diego, CA) or Expand PCR Systembility that Cr-1 may play a role in regulating cardiac gene
(Boehringer Mannheim, Indianapolis, IN) with following primerexpression. We used the ES3 model system to test this possi-
pairs. The Cr-1-speci®c primers, 5*-ACCTGCTCTGTGTCTCCT-bility.
GATTTCC-3* (p-1), which is outside (3*) of the targeting vector, and
5*-CACTAGGTGACCAATCTGGTCCAAC-3* (p-2), a neo gene-
speci®c primer, 5*-GCAGCCTCTGTTCCACATACACTTC-3* (p-
3), and a hyg gene-speci®c primer, 5*-TCACGTTGCAAGACC-MATERIALS AND METHODS
TGCCTGAAAC-3* (p-4). The PCR conditions were as follows:
947C for 4 min; 10 cycles of 947C for 10 s, 657C for 30 s, and 687C
for 4 min, and followed by 20 cycles of 947C for 10 s, 657C for 30Construction of targeting vectors. The targeting vectors were
constructed with the pPNT plasmid (Tybulewicz et al., 1991). In s, and 687C for 4 min with 20-s increments for each cycle and a
the vector pCR-KO1, a 5-kb 5* homologous sequence containing ®nal extension step at 727C for 10 min. Additional PCR reaction
exon 1 and 2 was inserted in front of a gene cassette encoding using primers within intron 3: 5*-GTCCCTGATAGTCTCTGA-
neomycin phosphotransferase (neo) gene under the control of the TATTC-3* (p-5) and 5*-GAAATGTAAGAAAAGTCATGGGG-3*
phosphoglycerokinase (PGK) promoter. A 3.8-kb 3* homologous (p-6) or a set of primer in neo gene: 5*-GTCAAGAAGGCGATA-
fragment containing exon 6 was cloned into the BamHI site down- GAAGGCGATGCG-3* (p-7) and 5*-GGTGGAGAGGCTATT-
stream to the neo. The targeting vector pCR-KO2 was prepared CGGCTATGACTG-3* (p-8) was also performed. The PCR reaction
by inserting the PGK±hygromycin (PGK±hyg) downstream of the for primer p-4/p-5 and p-6/p-7 was performed by denaturing the
PGK-neo in pCR-KO1. Negative selection to avoid random inser- DNA at 947C for 2 min, followed by 35 cycles of ampli®cation:
tion was provided by the herpes simplex virus thymidine kinase 947C for 30 s, 557C for 30 s, 727C for 1.5 min, and a ®nal extension
(hsv±tk) gene. step at 727C for 6 min.
Embryonic stem cell culture, electroporation, and selection. RT±PCR Analysis. Total RNA (3 mg) was isolated from ES cells
The ES cells were maintained in the undifferentiated state by cul- and EBs, treated with RNase-free DNaseI (Stratagene, San Diego,
ture on mitomycin C-treated mouse embryonic ®broblasts (MEF) CA) and converted into cDNA using oligo(dT) as a primer. The
feeder layers according the standard protocols. The medium used cDNA was ampli®ed by PCR using primers within the Cr-1 deleted
was high glucose Dulbecco's modi®ed Eagle's medium (DMEM) region, 5*-ATCGGTCTTTCCAGTTCGTGCCTTC-3* in exon 3
containing 15% fetal bovine serum, 0.1 mM b-mercaptoethanol, 1 and 5*-ATCTGCACAGGGAACACTTCTTGGG-3* in exon 5. A
mM sodium pyruvate, 11 nonessential amino acids, 2 mM gluta- set of primers for GAPDH (Hummler et al., 1996), 5*-CGTCT-
mine, 100 units penicillin/ml, 0.1 mg of streptomycin, and 2% TCACCACCATGGAGA-3* and 5*-CGGCCATCACGCCACAG-
leukemia inhibitory factor (LIF) (conditioned medium collected TTT-3*, was also added to the same reaction as controls. The cDNA
from con¯uent cultures of Chinese hamster ovary cells transfected from Day 10 EBs was ampli®ed by PCR using speci®c primers for
with the LIF expression plasmid provided by permission of the MLC2v (Miller-Hance et al., 1993); speci®c primers for ANF, 5*-
Genetics Institute, Andover, MA). The fetal bovine serum was ob- CGGTGTCCAACACAGATCTG-3* and 5*-TCTCTCAGAGGT-
tained from Tissue Culture Biologicals (Tulare, CA). GGGTTGAC-3*, which should give a 187-bp product; speci®c
For the generation of Cr-1 (//0) cells, 1 1 107 R1 ES cells were primers for desmin, 5*-TGATGAGGCAGATGAGGGAG-3* and
electroporated with 30 mg linearized pCR-KO1 plasmid DNA at 5*-TGAGAGCTGAGAAGGTCTGG-3*, which should give a 246-
300 V, 250 mF. Recombination events were selected with G418 (380 bp product, and GAPDH (Hummler et al., 1996). The cDNA from
mg/ml) and gancyclovir (0.2 mM). To disrupt the second allele, Cr- Day 6 EBs was ampli®ed by PCR using brachyury-speci®c primers,
1 (//0) E31 and E40 cells were electroporated with linearized vector 5*-ATCAAGGAAGGCTTTAGCAAATGGG-3* and 5*-GAACC-
TCGGATTCACATCGTGAGA-3*, which should give a 159-bp
product; GATA4 speci®c primers, 5*-CACTATGGGCACAGCA-
GCTCC-3* and 5*-TTGGAGCTGGCCTGCGATGTC-3*, which3 Abbreviations used: DMEM, Dulbecco's modi®ed Eagle's me-
should give a 143-bp product; Mef 2C-speci®c primers (Martindium; ES cells, embryonic stem cells; EB, embryoid body; KO,
et al., 1993); Nkx2.5-speci®c primers (Biben and Harvey, 1997),knockout; LIF, leukemia inhibitory factor; MEF, mouse embryonic
5*-TGCAGAAGGCAGTGGAGCTGGACAAGCC-3* and 5*-TTG-®broblasts; MHC, myosin heavy chain; MLC, myosin light chains;
CACTTGTAGCGACGGTTCTGGAACCAG-3*, which shouldPGK, phosphoglycerokinase; tk, thymidine kinase; SRF, serum re-
sponse factor. give a 220-bp product; Egr-1-speci®c primers, 5*-CCGAGCTCT-
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TCACACAACAACTTTTGTC-3* and 5*-CCGAGATCTCCCAG- Teratocarcinoma. Cells (61 106) were injected into two subcu-
taneous sites of 6-week-old 129SvJ mice. Five mice were used forCTCATCATCAAAC-3*, which should give a 355-bp product and
GAPDH primers. cDNA samples from Day 28 EB outgrowths were each cell line. The tumors were processed for histological analysis
3 weeks after the injection. The identi®cation of tissue types wastested for skeletal muscle differentiation by PCR using myogenin-
speci®c primers selected from sequences in GenBank: 5*-TGA- made by a board-certi®ed pathologist, Dr. D. Mercola, M.D., Ph.D.,
FACP.GGGAGAGCGCAGGCTCAAG-3* and 5*-TGCTGTCCACGAT-
GGACGTAAGG-3*, which should give a 361-bp product. cDNA
samples derived from Day 25 EB outgrowths were tested for neu-
ronal differentiation by PCR ampli®cation using light chain neuro- RESULTS
®lament-speci®c primers, derived from GenBank: 5*-CTCCTA-
CTTGATGTCTGCTCGC-3* and 5*-TCAGACTCATCCTTGGC- Targeting the Cripto-1 Gene in ES Cells byAGC-3*, which should give a 219-bp product.
Homologous RecombinationThe PCR reactions for Cr-1, GAPDH, desmin, brachyury,
GATA4, MEF2C, Egr-1, myogenin, and neuro®lament were per- To precisely de®ne the function(s) of Cr-1, we have dis-
formed by denaturing the DNA at 947C for 2 min, followed by 35 rupted both copies of the wild-type Cr-1 alleles sequentially
cycles of ampli®cation: 947C for 30 s, 60±657C for 30 s, 727C for by homologous recombination in R1 (Nagy et al., 1993) ES
1.5 min, and a ®nal extension step at 727C for 6 min. The RT±
cells. The two targeting vectors, pCR-KO1 and pCR-KO2,PCR assays for MLC2V were performed by denaturing the DNA
caused the replacement of Cr-1 exons 3, 4, and 5 by PGK-at 957C for 5 min, followed by 35 cycles of ampli®cation: 947C for
neo and by PGK-neo -hyg, respectively, as determined by30 s, 707C for 30 s, 727C for 30 s, and a ®nal extension step at
PCR analysis of genomic DNA (Figs. 1a±1d) and Southern727C for 6 min. The RT±PCR assays for ANF were performed by
blotting analysis (data not shown). To further con®rm thedenaturing the DNA at 957C for 5 min, followed by 35 cycles of
ampli®cation: 947C for 30 s, 557C for 30 s, 727C for 50 s, and a ®nal Cr-1 (0/0) mutation, reverse transcriptase±polymerase
extension step at 727C for 6 min. The RT±PCR assays for Nkx2.5 chain reaction (RT±PCR) was performed to examine
were made from cDNA converted by the Nkx2.5-speci®c 3* primer whether Cr-1 mRNA was present in the clones isolated. No
and performed by denaturing the DNA at 947C for 4 min, followed Cr-1 cDNA could be ampli®ed from homozygous mutant
by 35 cycles of ampli®cation: 947C for 30 s, 597C for 1 min, 727C cells while a 216-bp product was obtained from wild-type
for 1 min, and a ®nal extension step at 727C for 10 min.
and Cr-1 (//0) clones (Fig. 1e). In the same reaction, a 300-Western blotting. ES cells were cultured as aggregates to form
bp fragment of GAPDH was produced from all the samplesEBs that continuously produced many differentiated tissues during
(Fig. 1e). These tests con®rmed that the Cr-1 gene was com-the time frame (Keller, 1995). EBs derived from different cell lines
pletely inactivated in the R1-derived clones selected.during a time course of differentiation were dissolved in lysis buffer
(Laemmli, 1970), separated by SDS±PAGE, and then transferred
to polyvinyline di¯uoride membrane (Immobilon, Millipore Corp.,
ES Cell Differentiation as Aggregates in HangingBedford, MA) using standard Western blotting methods (Burnette,
Drops1981). The samples were detected for myosin heavy chain (MHC) by
a monoclonal antibody MF20 (Developmental Studies Hybridoma Mouse ES cells differentiate in vitro into a variety of cell
Bank, NICHD, NIH), for MLC2A by a rabbit antiserum (a kind gift
types including spontaneously contracting cardiac myo-from Dr. K. Chien, University of California at San Diego), for ErbB2
cytes (Keller, 1995). Since Cr-1 is expressed in the devel-and ErbB3 by rabbit antibodies (Santa Cruz Biotechnology Inc., CA),
oping heart during embryogenesis, we examined whetherand for AFP and laminin by rabbit antisera (Dziadek and Adamson,
Cr-1 knockout had any effect on cardiomyocyte formation1978; Grover et al., 1983). The blots were then incubated with the
peroxidase-labeled secondary antibodies. Signals for binding of the by in vitro differentiation analysis. Comparisons were made
antibodies were detected by enhanced chemiluminescence system among several clones, including wild-type R1, Cr-1 (//0)
(ECL Amersham Corp., Aylesbury, UK). For controls, the blots were E31, and E40, two independent Cr-1 (0/0) ES cell lines,
reprobed with mouse monoclonal antibodies against b-actin or a- DE7 and DE39, obtained from transfection of Cr-1 (//0)
actinin (Sigma, St. Louis, MO) using a method developed by (Kra- E31 cells, and two other independent Cr-1 (0/0) lines, DE14
jewski et al., 1996).
and DE48, derived from Cr-1 (//0) E40 cells. DifferentiatingStable transfection for rescue. Cells were cotransfected by lipo-
cultures were initiated by removing ES cells from the feederfectamine (Gibco-BRL, Gaithersburg, MD) and plasmid vectors con-
layer and forming size-controlled aggregates in hanging droptaining Cr-1 sense or antisense cDNA driven by the SV40 promoter
cultures (Wobus et al., 1991). All cell lines tested gave rise totogether with a plasmid DNA containing puromycin resistance
gene driven by the PGK promoter, according to the manufacturer's embryoid bodies (EBs) of similar sizes and gross morphology
recommendation. One week after the selection with 1.6 mg/ml pu- (data not shown). After 7 days in culture, spontaneously
romycin, resistant clones were pooled, expanded, and subjected to contracting EBs were observed in cells derived from wild-
the differentiation assay. type R1 cells. The beating activity was also observed in EBs
To test for the reexpression of Cripto-1 transcripts in these cul- derived from Cr-1 (//0) E31 and E40 after 9 days in culture.
tures, semiquantitative RT±PCR was performed. Each cDNA sam-
The duration of continuous spontaneous contractile activ-ple was 10-fold serially diluted and used as templates for the PCR
ity in cardiac myocytes from R1, E31, or E40 was 1 to 2ampli®cation with speci®c primers for the Cr-1 gene, using
weeks. In contrast, no beating cardiac cells were observedGAPDH gene transcripts as loading controls. The DNA bands pro-
in EBs derived from any of the four independent Cr-1duced after 35 cycles of PCR were matched to compare levels be-
tween cell lines. (0/0) ES clones tested (Table 1), even during culture for an
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FIG. 1. Generation of Cr-1 (0/0) cells. (a and b) Strategies for disrupting Cr-1 alleles. Exons are depicted by the open boxes and numbered.
B represents BamHI. (c and d) Genotyping of cell lines. The primer p-3 and p-1 ampli®ed a 4.2-kb product in Cr-1 (//0) clones and 4.2-kb and
6.8-kb products in Cr-1 (0/0) cells (under neo). The p-1 and p-2 ampli®ed a 4.8-kb product from Cr-1 (///) and (//0) cells (under wt). The p-
4 and p-1 gave a 5.2-kb product only in the Cr-1 (0/0) cells (under hyg). The p-5 and p-6 ampli®ed a 242-bp product from Cr-1 (///) or (//0)
cells while the p-7 and p-8 ampli®ed a 739-bp product from Cr-1 (//0) and (0/0) cells. (e) RT±PCR veri®cation of Cr-1 mutations.
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TABLE 1
Inhibition of Cardiomyocyte Differentiation in Cr-1 (0/0) Cells
Percentage of EBs with beating cardiomyocyte
No. of
Cells EBs D6 D7 D8 D9 D10 D11 D12 D13 D14
R1 (///) 55 0 32.7 52.7 58.2 38.2 32.7 14.5 9.0 7.2
E31 (//0) 46 0 0 0 4.3 10.9 8.7 2.2 2.2 2.2
E40 (//0) 49 0 0 0 18.4 30.6 34.7 24.5 24.5 16.3
DE29 (//0) 37 0 0 0 5.4 13.5 10.8 10.8 8.1 5.4
DE32 (//0) 48 0 0 14.5 20.8 29.2 14.6 12.5 12.5 10.4
DE7 (0/0) 52 0 0 0 0 0 0 0 0 0
DE14 (0/0) 43 0 0 0 0 0 0 0 0 0
DE39 (0/0) 46 0 0 0 0 0 0 0 0 0
DE48 (0/0) 34 0 0 0 0 0 0 0 0 0
DE7S 41 0 0 0 2.4 4.9 7.3 7.3 4.9 2.4
DE7A 45 0 0 0 0 0 0 0 0 0
Note. EBs were cultured from wild-type ES cells, R1(///), from cell lines with one Cr-1 allele mutated, E31 and E40 (//0), from cell
lines with both Cr-1 alleles mutated, DE7 (0/0) and DE39 (0/0) (derived from E31), DE14 (0/0), and DE48 (0/0) (derived from E40).
Cells that remained heterozygous after the hygromycin selection, DE29 (//0) and DE 32 (//0), were also tested for the ability and timing
of beating cardiomyocyte formation. DE7(0/0) cells transfected with a plasmid containing Cr-1 sense, population DE7S, or antisense Cr-
1 cDNA, population DE7A, were monitored for beating cardiomyocyte aggregates from Days 6 to 14. The rescue of beating in Cr-1(0/0)
cells occurred only in the sense-expressing cultures. Similar results were found in more than three independent experiments. D, day.
additional 10 days (data not shown). Furthermore, in addi- differentiate into beating cardiomyocytes while a popula-
tion of cells selected after transfection with antisense Cr-tion to the difference in the time for the ®rst appearance of
beating, the wild-type R1 cells gave rise to a higher percent- 1, DE7A, were still unable to differentiate (Table 1). The
percentage of EBs that resumed beating was lower than inage of beating EBs than Cr-1 (//0) cell lines, indicating this
effect was dose-dependent (Table 1). These results indicate wt ES cells because in cotransfections not all the cells in
the puromycin-resistant population take up and express thethat the formation of cardiac myocytes was completely
blocked by Cr-1 mutations in ES cells. Inactivation of Cr- Cr-1 gene. The expression of Cr-1 mRNA in cultures that
were ``rescued'' for the beating phenotype was con®rmed1 did not appear to in¯uence cell growth of undifferentiated
mouse ES cells as measured by proliferation assays (data by the detection of Cr-1 mRNA only in rescued DE7S-
(0/0R) cells, in Cripto-1 (//0) (Fig. 2) and in wt ES culturesnot shown), although growth inhibition was reported for a
human teratocarcinoma cell line treated with an antisense (Fig. 1). Semiquantitative analysis of the relative expression
of Cr-1 in rescued clones showed that about 10-fold lessCR-1 vector (Baldassarre et al., 1996).
The observed phenotype was not due to clonal variation Cr-1 was expressed in the rescued population than in the
heterozygous (//0) cells (Fig. 2). In accord with these levelssince four independent Cr-1 (0/0) clones derived from
transfection of two Cr-1 (//0) cell lines displayed the same of Cr-1 expression, the frequency of beating reached 7% in
rescued cells versus 35% in heterozygous cells. Therefore,phenotype while none of the Cr-1 (///) or (//0) cell lines
was defective in cardiac myocyte formation. Nor was the
phenotype a result of the drug selection, since two clones,
DE29 and DE32, that remained heterozygous after the hy-
gromycin selection formed beating EBs with similar per-
centages to Cr-1 (//0) cell lines (Table 1).
Rescue of the Mutant Phenotype
To de®nitively con®rm that the block to cardiac differen-
FIG. 2. Semiquantitative RT±PCR analysis of Cr-1 RNA expres-tiation was due to the inactivation of Cr-1, we cotransfected
sion in Cr-1 (//0) and rescued Cr-1 (0/0R) cells. Cr-1 expressionone Cr-1 (0/0) cell line DE7 with a full-length Cr-1 sense
was estimated using 10-fold serial dilutions of cDNA that were
or antisense expression plasmid together with a plasmid subjected to the PCR analysis using two sets of primers designed
for puromycin resistance. Stable clones were selected for to detect Cr-1 and GAPDH. RNA isolated from Cr-1 (//0) E40
resistance to puromycin, pooled as a population of cells, cells, Cr-1 (0/0) DE7 cells, and rescued Cr-1 (0/0R) DE7S cells
and examined for cardiac differentiation. The resulting pop- were compared by reference to the signal observed as ethidium
bromide-stained ampli®ed DNA in each dilution series.ulation, DE7S, was found to have regained the ability to
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FIG. 3. (a) Western blot analysis of EBs. EBs derived from indicated cell lines at the speci®c day were detected for myosin heavy chain
(MHC) by a monoclonal antibody MF20 (Developmental Studies Hybridoma Bank, NICHD, NIH), for MLC2A by a rabbit antiserum (a
kind gift from Dr. K. Chien, Dept. of Medicine, University of California at San Diego), for ErbB2 and ErbB3 by rabbit antibodies (Santa
Cruz Biotechnology Inc. CA), and for AFP and laminin by rabbit antisera. For a control, the blot was reprobed with antibody against b-
actin or a-actinin. Signals for binding of the antibodies were detected by the enhanced chemiluminescence system (b) RT±PCR detection
of MLC 2V, ANF, and GAPDH in Day 10 EBs; brachyury, GATA4, Mef2C, Nkx2.5, Egr-1, and GAPDH in Day 6 EBs.
differentiation to cardiomyocytes is speci®cally restored by compared to that of wild-type EBs. In contrast, expression
of MHC in Cr-1 (0/0) EBs was undetectable. Similarly, ex-Cr-1 while differentiation is speci®cally blocked by the in-
pression of MLC2A was observed only in the wild-type andactivation of the Cr-1 gene.
Cr-1 (//0)-derived EBs but not in Cr-1 (0/0) EBs. Tran-
scripts of cardiac-speci®c myosin light chain 2V (MLC2V)
were undetectable in Cr-1 (0/0) EBs as examined by RT±Assays for Markers of Cardiac Differentiation
PCR (Fig. 3b, line 1). The expression of myosin polypeptides
To determine where Cr-1 might be acting during the pro- precedes contractile activity and so components upstream
cess of cardiac differentiation, we examined the expression of the myosin induction pathway must be affected. An early
of the myosin heavy chain (MHC) and the cardiac-speci®c marker of muscle cell differentiation, desmin, the interme-
myosin light chain 2A (MLC2A), two major contractile pro- diate ®lament protein, was present as transcripts in both
teins of cardiomyocytes, in 10-day old EBs from each cell wild-type and mutant cell cultures (data not shown), while
type by Western blotting. As shown in Fig. 3a, the strongest transcripts of a later marker of heart differentiation, atrial
signal for MHC was detected in EBs derived from wild- natriuretic factor (ANF) were absent only in the mutant 10
day EB cultures (Fig. 3b, line 2).type R1 cells. Cr-1 (//0)-derived EBs gave weaker signals
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As detected by RT±PCR, transcripts of precardiac meso- started strongly in the dense clusters of attached wild-type
R1 aggregates but was never observed in the Cr-1 (0/0)derm markers, transcriptional factors GATA4 (Edmondson
et al., 1994; Heikinheimo et al., 1994), were present in Cr- cells as described above, in agreement with the absence of
MLC2A in outgrowths of Cr (0/0) EBs (data not shown).1 (0/0) cell culture (Fig. 3b). The homeobox gene, Nkx2.5,
is related to tinman in Drosophila, where it is known to be Small myotubes started to form in both wild-type and mu-
tant cell cultures after 2 weeks in culture and myotubesessential for heart formation and has been implicated in the
early stages of mouse cardiac myogenesis and morphogene- continued to grow into large skeletal muscle-like myotubes
(Fig. 4a) that contained multiple nuclei and contracted fre-sis (Lints et al., 1993) in mice produced using knockout
technology (Biben and Harvey, 1997; Lyons et al., 1995). To quently on Days 20±25. The formation of skeletal muscle
was further con®rmed by expression of a skeletal-speci®cdetermine if Cr-1 acted upstream of the expression of this
gene, we analyzed differentiating EBs for Nkx2.5 mRNA by gene, myogenin, as detected by RT±PCR. Transcripts were
detected in RNA extracts of all differentiated ES cell linesRT±PCR. As shown in Fig. 3b, transcripts of Nkx2.5 were
detectable in Cr-1 (0/0) EBs. Egr-1, another transcription tested whether Cr-1 expressing or not (Fig. 5, top line).
Differentiation into other mesoderm and into other cellfactor, which has been shown to be involved in stimulation
of cardiac MHC expression (Gupta et al., 1991), is expressed types was demonstrated by the generation of teratocarcino-
mas, which form a wide range of recognizable differentiatedand is not affected by inactivation of Cr-1 (Fig. 3b). Expres-
sion of ErbB2 and ErbB3 in Cr-1 mutant EBs was not signi®- cell types. To examine differentiation in vivo, wild-type R1
cells and Cr-1 (0/0) DE39 cells were injected (sc) into 129cantly different from wild-type EBs (Fig. 3a). This family of
genes are involved in later stages of cardiac development SvJ mice. After 3 weeks, tumors formed from both the mu-
tant cells and wild-type cells and examination of hematoxy-because inactivation of ErbB2, ErbB3, ErbB4, and heregulin
in mice leads to inhibition of cardiac muscle trabeculae lin and eosin-stained sections indicated that the teratocarci-
nomas contained many cell types. Dermis and squamousformation and causes midgestational death (Erickson et al.,
1997; Gassmann et al., 1995; Lee et al., 1995; Meyer and epidermis (Fig. 4c), cartilage (Fig. 4d), and epithelioid organs
(Fig. 4e) were observed in teratocarcinomas derived fromBirchmeier, 1995).
The muscle-speci®c actin genes occur in four isoforms in both cell lines. Therefore, inactivation of Cr-1 did not affect
differentiation of other mesoderm cell types in spite of thecardiac, skeletal, enteric, and vascular muscle cells. Their
ontogenesis has been described in ES cells and cardiac a- inability to differentiate into cardiomyocytes.
To test if the mutant cells can differentiate into neurons,actin; transcripts appear on Day 5 of differentiation (Ng et
al., 1997). We used the same experimental approach to assay an ectoderm-derived cell type, the EBs were treated with
trans-retinoic acid which enhances neural differentiationfor the appearance of cardiac a-actin transcripts in ES and
differentiated EBs. In contrast to Ng et al., we found that (Levine and Flynn, 1986) and then plated on gelatin-coated
dishes. One week after plating, cells with neuron-like mor-even undifferentiated ES cells express transcripts for a-car-
diac actin and continue to do so throughout the time course phology were found in the culture. Figure 4b shows neurite
outgrowths in the Cr-1 (0/0) cell culture 2 weeks afterof differentiation. This was tested using the same condi-
tions for RT±PCR as described by Ng et al., as well as using plating. The axonal-like outgrowths expressed neuro®la-
ment transcripts because RT±PCR assays were positivedifferent primers under more stringent conditions (data not
shown). The same positive result was obtained for both Cr- (Fig. 5, lower panel) in differentiated cell cultures irrespec-
tive of Cr-1 expression.1 (0/0) and Cr(///) genotypes, indicating that this gene is
poorly regulated in ES cells, and is not a good marker for To determine if inactivation of Cr-1 affects the differenti-
ation of endoderm, the expression of a-fetoprotein (AFP), acardiac speci®c differentiation.
marker for visceral endoderm cells, and laminin, a marker
for parietal endoderm cells among other tissues, was not
Assays for Markers of Other Differentiated Tissues signi®cantly different in mutant EBs at Day 8 from those
in wild-type cells as determined by Western blotting analy-To test the possibility that Cr-1 disrupts early stages of
mesoderm differentiation, we examined the expression of sis (Fig. 3a). Thus, Cr-1 is not required for differentiation of
endoderm.an early mesoderm marker, brachyury (T) (Wilkinson et al.,
1990), since cardiomyocytes are mesoderm-derived. As
shown in Fig. 3b, brachyury transcripts were present in 6-
day EBs derived from all cell lines tested, including wild- DISCUSSION
type R1, two Cr-1 (//0) cell lines, and four Cr-1 (0/0) cell
lines as detected by RT±PCR. Therefore, inactivation of Cr- Functional and biochemical differentiation is readily
studied using ES cells because of their ability to differentiate1 did not affect expression of this early mesoderm marker.
We then evaluated the role of Cr-1 on the generation of into a range of cell types in culture and into teratocarcino-
mas in adult hosts. The in vitro model of cardiogenesisother mesoderm-derived cell types such as skeletal muscle
by culturing EBs on gelatin-coated dishes. Both wild-type using ES cells has been well characterized and the temporal
stages in cardiomyocyte differentiation and function haveand mutant EBs attached to the dishes within 1 day and
differentiating cells grew outward. Cardiac contraction been mapped, although spatial signals and morphogenesis
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FIG. 4. In vitro and in vivo differentiation of Cr-1 (0/0) cells. (a) Differentiation of Cr-1 (0/0) cells into skeletal muscle. EBs derived
from the Cr-1 (0/0) cell line DE39 were formed by hanging drops and transferred to gelatin-coated dishes on Day 5. Strongly contracting
myotubes around the attached EBs were observed after culture for an additional 2 weeks. (b) Differentiation of Cr-1 (0/0) cells into
neurons. The EBs were also treated with 5 1 1007 M retinoic acid on Days 5±8 and transferred to gelatin-coated dishes after partial
dissociation with trypsin±EDTA. Neurons were formed after plating. (c, d, e) Stained sections (hematoxylin and eosin) of teratocarcinomas
derived from Cr-1 (0/0) ES cells. The tumors derived from Cr-1 (0/0) DE39 cells were ®xed, embedded, and sectioned at 5 mm. Sections
stained with hematoxylin and eosin contained readily recognizable dermis and squamous epidermis (c), cartilage (d), and epithelioid organs
(e). Bar, 100 mm.
are lacking in this model (Fassler et al., 1996; Maltsev et cells to the cardiac lineage (reviewed in Baker and Lyons,
1996). However, inactivation of these genes in mice did notal., 1993; Metzger et al., 1996; Miller-Hance et al., 1993;
Wobus et al., 1995). affect differentiation of cardiomyocytes, but affected later
events in cardiogenesis (Lyons, 1996; Olson and Srivastava,Based on our results of in vitro and in vivo differentiation
of ES cells, we concluded that disruption of Cr-1 results in 1996). All of the transcription factors that we assayed that
were shown to be involved in cardiac development werea speci®c defect in cardiac differentiation but there is no
detectable defect in differentiation of other mesodermal, transcribed in Cripto null ES cell cultures. Therefore Cripto
acts independently of the expression of these genes. Otherendodermal and ectodermal cell types. These results em-
phasize a potentially important function for Cr-1 in cardio- than bone morphogenetic protein (BMP4) in chicks (Schul-
theiss et al., 1997) and mouse (Winnier et al., 1995) andmyocyte differentiation at an early stage of cardiac develop-
ment, which is consistent with predictions based on the hepatocyte growth factor (HGF) in mouse (Rappolee et al.,
1996) very little is known about how growth factors affectexpression pattern of Cr-1 during mouse embryogenesis.
Several transcription factor genes expressed in precardiac early cardiogenesis.
The use of ES cells to model differentiation in vitro allowsmesoderm, such as Nkx2.5 (Biben and Harvey, 1997; Har-
vey, 1996), Mef2C (Lyons et al., 1995); Edmondson et al., the identi®cation of induced gene activity in a temporal
fashion but, except for a few good examples, such as neu-1994) (Lin et al., 1997), GATA4 (Heikinheimo et al., 1994;
Kuo et al., 1997; Molkentin et al., 1997), eHAND (Cserjesi ronal differentiation (Levine and Flynn, 1986), it is an inade-
quate model for de®ning the events in a single pathwayet al., 1995), and dHAND (Srivastava et al., 1997) were pre-
dicted to be responsible for the commitment of mesodermal leading to de®ned cell types. This is because, without ma-
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members and serum response factor (SRF), and it is thought
that speci®c combinations of factors modulate the type and
activities of the developing muscle cells (Firulli and Olson,
1997). We describe here for the ®rst time that inactivation of
the growth factor gene, Cr-1, results speci®cally in defective
early differentiation of cardiomyocytes due to the absence
of contractile muscle proteins. This phenotype was speci®c
to cardiogenesis because no other major tissue type was
absent. The abrogation of the Cripto-1 gene was the cause
of the phenotype because the reexpression of exogenous
Cripto-1 in the ``knockout'' cells reversed the mutant phe-
FIG. 5. RT±PCR analysis of myogenin and neuro®lament expres- notype. We speculate that Cripto-1 may be a master switch
sion in EB outgrowths. Cr-1 (///), Cr-1 (//0), and Cr-1 (0/0) cell gene that activates the myosin genes in the cardiomyocyte
aggregates (EBs) were induced to differentiate into the structures via activation of the Ras/MAPK pathway (Kannan et al.,
shown in Fig. 4a, skeletal muscle, or Fig. 4b, neurons (see Materials 1997) that could lead to activation of the SRF gene (Dono-
and Methods). The cDNA samples from differentiated cultures
viel et al., 1996) and other type-speci®c combinatorial tran-were processed by PCR using primers speci®c for myogenin or
scription factor genes.neuro®lament. The predicted DNA bands were produced in all cul-
The unique speci®city of Cripto-1 for cardiac cell differen-tures irrespective of Cr-1 expression.
tiation is unusual because most factors activate both cardiac
and skeletal muscle lineages. Possibly the EB provides the
correct juxtaposition of primitive endoderm overlaying pre-
cardiac mesoderm, a combination shown to be heart-induc-nipulation, multiple differentiation pathways occur simul-
taneously. Fortunately for this analysis, cardiomyocyte dif- tive in Xenopus (Nascone and Mercola, 1995). The result is
that Cr-1 is produced and this, in turn, induces unknownferentiation is one of the earliest events and these cells start
to beat on the seventh day of EB differentiation, reaching target genes which in combination lead to cardiomyogen-
esis.an incidence of 50% of total EBs. But even single EBs
contain mixtures of several cell types and these differ be- To devise strategies for cardiac muscle cell transplanta-
tion in heart disease treatments (Field, 1993) it will be help-tween EBs and between cultures. Our ®nding that transcrip-
tion factors thought to be speci®c to cardiac lineage are ful to de®ne how speci®c growth factors such as Cr-1 pro-
mote cardiac lineages. Thus, these Cr-1 (0/0) and otherexpressed in this mixture of cell types does not allow assign-
ment of activities that are downstream or upstream of Cr- targeted ES cell lines will provide a good system for studying
speci®cation and differentiation of the cardiac lineage and1 in cardiomyogenesis because independent pathways are
mixed together. For instance, in our cultures there was al- may provide information for therapy programs aimed to-
ward regeneration of myocardium.ways AFP-producing visceral endoderm, and these cells also
express GATA-4 (Heikinheimo et al., 1994). Primitive endo-
derm and thyroid primordium as well as precardiomyocytes
express Nkx2.5 (Lints et al., 1993). Mef2c is not speci®c ACKNOWLEDGMENTS
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